RIYADH, SAUDI ARABIA / ACCESSWIRE / October 2, 2023 / Under the patronage of His Highness Prince Badr bin Abdullah bin Farhan Al Saud, Minister…
Critical findings from a comprehensive study on child safety products raise urgent concerns, prompting a call for enhanced safety standards and heightened vigilance among parents…
Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to…
A new Syn (Synergetic) genre classification gives music artists a category to showcase AI work. SALT LAKE CITY, UT / ACCESSWIRE / September 26, 2023…
Financial Losses are a Major Consequence of Cyber Scams, But Finance Leaders Now Have a New Resource to Help Them Upgrade Processes and Fortify Their…
TORONTO, ON / ACCESSWIRE / September 25, 2023 / Forum Asset Management Inc. collectively with its affiliates (“Forum”), announce the appointment of Andrew J. Kavouras…
Eviosys debuts a brand-new ultra-light shallow metal overcap for tins – Horizon – at London Packaging Week 2023. The new metal lid is industry leading,…
RAS AL KHAIMAH CITY, UAE / ACCESSWIRE / September 20, 2023 / Held under the patronage of His Highness Sheikh Saud bin Saqr Al Qasimi,…
HotelRunner, the leading hospitality and travel technology provider, proudly announces its acquisition of PayPad, a high-end point-of-sale system, and revamps it as HotelRunner POS, cementing…
SEOUL, SOUTH KOREA / ACCESSWIRE / September 17, 2023 / Habitus Associates Co., LTD., the entity behind the online art platform ‘Artue’ and under the…
PALO ALTO, CA / ACCESSWIRE / September 15, 2023 / Nanofiber Quantum Technologies Inc. (“NanoQT”) raised $8.5m from leading venture capital investors. Phoenix Venture Partners…
WINCHESTER, ENGLAND / ACCESSWIRE / September 14, 2023 / Cats may not be quite as carnivorous as once thought. Whilst biologically carnivorous, cats are increasingly…
Supporting UNESCO’s Convention for the Safeguarding of Intangible Cultural Heritage LOS ANGELES, CA / ACCESSWIRE / September 13, 2023 / Better Worlds in partnership with…
Initiative Is Joined by Major Market Participants Like Accenture, Bayer, and Oliver Wyman; Sets Goal of $1B in Funding NEW YORK, NY / ACCESSWIRE /…
SAN FRANCISCO, CA / ACCESSWIRE / September 12, 2023 / Anglepoint, the industry leader in Software Asset Management (SAM) Services for the Forbes 2000, will…
Unbiased and Multimedia Web3 Insights DUBAI, ARAB EMIRATES / ACCESSWIRE / September 10, 2023 / Web3 multimedia outlet Crypto Presale announces its grand entrance into…
CASA23: Powering the CPaaS industry’s growth to $100B with global innovators at the world’s first CPaaS-dedicated event AMSTERDAM, NETHERLANDS / ACCESSWIRE / September 6, 2023…
The expanded partnership between FeedbackFruits and D2L will help provide D2L Brightspace users with scalable pedagogical solutions for peer feedback, social annotation, team-based learning and…
SEOUL, SOUTH KOREA / ACCESSWIRE / September 1, 2023 / On September 7th, Cahiers d’Art will officially launch its first expansion in Asia and announce…
SHANGHAI, CHINA and TAIPEI, TAIWAN / ACCESSWIRE / August 28, 2023 / HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development…
Latest News
Australian researchers from Adelaide University and the Olivia Newton-John Cancer Research Institute have identified a novel molecular switch that drives the spread of aggressive tumors. Published in EMBO Molecular Medicine, the breakthrough study reveals that Australian researchers uncover a promising new way to tackle triple-negative breast cancer by restoring a critical regulatory molecule known as miR-342. The discovery opens new avenues to prevent life-threatening secondary cancers in organs such as the lungs and bones. Triple-negative breast cancer accounts for 10% to 15% of Australia’s approximately 21,000 annual breast cancer diagnoses but causes a disproportionate number of deaths. Lead investigators demonstrated that when miR-342 levels fall, a cancer-driving pathway called E2F becomes overactive, allowing dormant cancer cells to spread throughout the body and form dangerous secondary tumors.


